BOIRF
Price
$24.50
Change
+$0.20 (+0.82%)
Updated
Aug 29 closing price
Capitalization
560.09M
Intraday Buy/Sell Signals
BSPK
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
Capitalization
2.68M
Intraday Buy/Sell Signals
Interact to see
Advertisement

BOIRF vs BSPK

Header iconBOIRF vs BSPK Comparison
Open Charts BOIRF vs BSPKBanner chart's image
Boiron
Price$24.50
Change+$0.20 (+0.82%)
Volume$800
Capitalization560.09M
Bespoke Extracts
Price$0.24
Change-$0.00 (-0.00%)
Volume$6.19K
Capitalization2.68M
BOIRF vs BSPK Comparison Chart in %
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOIRF vs. BSPK commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOIRF is a Hold and BSPK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (BOIRF: $24.50 vs. BSPK: $0.24)
Brand notoriety: BOIRF and BSPK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BOIRF: 119% vs. BSPK: 100%
Market capitalization -- BOIRF: $560.09M vs. BSPK: $2.68M
BOIRF [@Pharmaceuticals: Generic] is valued at $560.09M. BSPK’s [@Pharmaceuticals: Generic] market capitalization is $2.68M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOIRF’s FA Score shows that 1 FA rating(s) are green whileBSPK’s FA Score has 0 green FA rating(s).

  • BOIRF’s FA Score: 1 green, 4 red.
  • BSPK’s FA Score: 0 green, 5 red.
According to our system of comparison, both BOIRF and BSPK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOIRF’s TA Score shows that 4 TA indicator(s) are bullish while BSPK’s TA Score has 2 bullish TA indicator(s).

  • BOIRF’s TA Score: 4 bullish, 0 bearish.
  • BSPK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BOIRF is a better buy in the short-term than BSPK.

Price Growth

BOIRF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while BSPK (@Pharmaceuticals: Generic) price change was -24.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BOIRF($560M) has a higher market cap than BSPK($2.68M). BSPK YTD gains are higher at: 294.737 vs. BOIRF (-14.035).
BOIRFBSPKBOIRF / BSPK
Capitalization560M2.68M20,919%
EBITDAN/A-767.07K-
Gain YTD-14.035294.737-5%
P/E Ratio18.95N/A-
RevenueN/A1.23M-
Total CashN/A1.36K-
Total DebtN/A1.46M-
FUNDAMENTALS RATINGS
BOIRF vs BSPK: Fundamental Ratings
BOIRF
BSPK
OUTLOOK RATING
1..100
4592
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
70100
PRICE GROWTH RATING
1..100
8037
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BOIRF's Valuation (6) in the null industry is significantly better than the same rating for BSPK (95). This means that BOIRF’s stock grew significantly faster than BSPK’s over the last 12 months.

BOIRF's Profit vs Risk Rating (100) in the null industry is in the same range as BSPK (100). This means that BOIRF’s stock grew similarly to BSPK’s over the last 12 months.

BOIRF's SMR Rating (70) in the null industry is in the same range as BSPK (100). This means that BOIRF’s stock grew similarly to BSPK’s over the last 12 months.

BSPK's Price Growth Rating (37) in the null industry is somewhat better than the same rating for BOIRF (80). This means that BSPK’s stock grew somewhat faster than BOIRF’s over the last 12 months.

BOIRF's P/E Growth Rating (74) in the null industry is in the same range as BSPK (100). This means that BOIRF’s stock grew similarly to BSPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BOIRFBSPK
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
15%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
10%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
10%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
18%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDLSX19.990.15
+0.76%
Fidelity Select Leisure
WCMFX11.320.05
+0.44%
WCM SMID Quality Val Fd Institutional
DQIAX34.960.15
+0.43%
BNY Mellon Equity Income Fund A
DFALX33.430.02
+0.06%
DFA Large Cap International I
TARKX34.95-0.21
-0.60%
Tarkio

BOIRF and

Correlation & Price change

A.I.dvisor tells us that BOIRF and ELAN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOIRF and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOIRF
1D Price
Change %
BOIRF100%
N/A
ELAN - BOIRF
21%
Poorly correlated
+4.39%
BUDZ - BOIRF
7%
Poorly correlated
+5.44%
BSPK - BOIRF
4%
Poorly correlated
N/A
APNHY - BOIRF
3%
Poorly correlated
N/A
BIOVF - BOIRF
1%
Poorly correlated
N/A
More

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
N/A
AVCNF - BSPK
9%
Poorly correlated
-8.31%
CHSYF - BSPK
9%
Poorly correlated
N/A
CAIHF - BSPK
4%
Poorly correlated
N/A
BOIRF - BSPK
4%
Poorly correlated
N/A
ARSUF - BSPK
2%
Poorly correlated
N/A
More